What is the ECLIPSE trial and where can I find more information?

ECLIPSE is a registrational trial evaluating the performance of Guardant Health’s blood-based test in ~13,000 patients aged 45-84 with an average risk for CRC. The primary objective is to evaluate the performance of our test compared to screening colonoscopy. We expect data from this trial to support a submission to the FDA.9,10

More information can be found on guardanthealth.com/clinical-studies/.